{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"hyperprolinemia-type-1","columns":[{"gene":"","key":"population-e82009dfd802bfc801d4","label":"Hyperprolinemia, type I","mondoId":"MONDO:0009400","onsetQualifier":null,"originColumnKey":"MONDO:0009400/OMIM:239500","originalViews":[{"key":"MONDO:0009400/OMIM:239500","label":"Hyperprolinemia, type I","scopeLabel":"OMIM:239500","sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"recordKeys":["13f6599e6bf10c402b470ef616e93f065838cea0a870fdd18cc5f81e8f17e8ad","1cbb9bf40de31b0ab0805af27cf5917fec22163d22a22c2e3d22700ef6f880f0","3172f9ab80ecd4440659a4aecf00d614bfcfb32b6d0dc50cf836ff3f3bc2d42c","346bf343cdc9a00c0800b36c2b3326321de2d47686d8b0eef4f69fc89969cf2d","38f5f3c7cc2332adb487043904c80a40efd7c86643ed2983710e2a2dc99581a3","4ebccbbad7048098d1810fccc3dc7dda92fd971818f9993649bc5fa45aa21af6","5647f554fd1f9ab5bd410234dafe5a4f15aff16b5750f316eb85391be2219055","650b36fb138a6338b42644d9fda33283093ad9d12cac3bf94a452ef9cef98482","84d03eed7b7987d4a7cf4d852e59d7a84cfe48e48bf403cbf24b3a2171e79adc","8b73a61b4ec70b9c923900ca5c03635ec5fb9bc2bc8a50296d80b3eaefd9d58c","ad113bfd349c92835fedd595ba3a540543574e8e6fbede90d27c7b9e1ba7ab97","ae56960bd0d7e9f9aa0dc546a33debe5ad252ddb02dc2364c0c5964d65d7223a","aedb75782fcb68c3c361371e8ada2a760c03d8cddd3475d64ab87c86076e8c3d","ba6549bf27fd8795134b5ed0f1535c179adb973d23e2b3fecdcde6efc13c8699","c33ebd59e91d60790a1dfeef1d0431d76a22c409b3e69d6d8b2afc8b4d0607eb","c645b3c917a49e480b9d7b52ac3e8a9b9b711e486afd92df31e55043c8d6b21f","e0086ecc17497a1d39d3bb438ef0d6fb2bea20e96463ecc91cb995873c3dac9c","f58b526160feee7de6348b47adbb0cfd6bd89e7ecc722bcd225a08ae4e1409b5"],"recordQualifiers":{},"scopeLabel":"OMIM:239500","sourceIds":["OMIM:239500"],"sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."},{"gene":"","key":"population-83f5feb320768048a66a","label":"Hyperprolinemia type 1","mondoId":"MONDO:0009400","onsetQualifier":null,"originColumnKey":"MONDO:0009400/ORPHA:419","originalViews":[{"key":"MONDO:0009400/ORPHA:419","label":"Hyperprolinemia type 1","scopeLabel":"ORPHA:419","sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"recordKeys":["0ce954ae410912b0d008ede4f1550503ed0e267e50deac541bb74a2df6e4ef09","1fd75d7cd3c6bcd740eae467c0e70289f4cfc73b40174963cbce0e5def5de9c3","33fb939f796da244c6099da224d47b2a4dd8318f7888f86dd1047cb0bc8efe0f","440f3e323bff118d3e26cdae823667be6b1cc563b9b6496e6b89ebcb3f92e5d5","4bae7a9cc2d5b500b602965cd27b0c8c59a4c81fedbfacea707e01e4fdb49e3b","e93d951b3e5e9f3b652196df1e998e57c1a5213ffc1e306b89acc1f1702edb03"],"recordQualifiers":{},"scopeLabel":"ORPHA:419","sourceIds":["ORPHA:419"],"sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":["population-e82009dfd802bfc801d4","population-83f5feb320768048a66a"],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":["HP:0000718","HP:0001251","HP:0000729","HP:0000750","HP:0002353","HP:0001290","HP:0001263"],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":8,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":24,"sourceGroups":{"omim":10,"orphanet":6,"published":8}},"features":[{"hpoId":"HP:0000718","label":"Aggressive behavior","primary":true},{"hpoId":"HP:0001251","label":"Ataxia","primary":true},{"hpoId":"HP:0000729","label":"Autistic behavior","primary":true},{"hpoId":"HP:0000750","label":"Delayed speech and language development","primary":true},{"hpoId":"HP:0002353","label":"EEG abnormality","primary":true},{"hpoId":"HP:0001290","label":"Generalized hypotonia","primary":true},{"hpoId":"HP:0001263","label":"Global developmental delay","primary":true},{"hpoId":"HP:0003080","label":"Hydroxyprolinuria","primary":false},{"hpoId":"HP:0000752","label":"Hyperactivity","primary":false},{"hpoId":"HP:0003108","label":"Hyperglycinuria","primary":false},{"hpoId":"HP:0008358","label":"Hyperprolinemia","primary":false},{"hpoId":"HP:0001252","label":"Hypotonia","primary":false},{"hpoId":"HP:0001249","label":"Intellectual disability","primary":false},{"hpoId":"HP:0000733","label":"Motor stereotypy","primary":false},{"hpoId":"HP:0000112","label":"Nephropathy","primary":false},{"hpoId":"HP:0003137","label":"Prolinuria","primary":false},{"hpoId":"HP:0000093","label":"Proteinuria","primary":false},{"hpoId":"HP:0100753","label":"Schizophrenia","primary":false},{"hpoId":"HP:0001250","label":"Seizure","primary":false},{"hpoId":"HP:0002133","label":"Status epilepticus","primary":false}],"ledeHtml":"Hyperprolinaemia type I is an inborn error of proline metabolism characterized by elevated levels of proline in the plasma and urine. The prevalence is unknown. The disorder is generally considered to be benign but associations with renal abnormalities, epileptic seizures, and other neurological manifestations, as well as certain forms of schizophrenia have been reported. It is transmitted as an autosomal recessive trait and is caused by mutations in the proline dehydrogenase or proline oxidase gene (PRODH or POX, 22q11.2).","mondoId":"MONDO:0009400","node":{"canonicalSlug":"hyperprolinemia-type-1","comparisons":[{"documentSha256":"3448f9936310db02e893133cd45ec84c4b7365369b158fa95acf0407b8a37a61","key":"legacy-hyperprolinemia","kind":"legacy","label":"hyperprolinemia","memberIds":["MONDO:0009400","MONDO:0009401","MONDO:0023419"],"mondoId":"MONDO:0023419","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/hyperprolinemia.3448f9936310db02e893133cd45ec84c4b7365369b158fa95acf0407b8a37a61.json"}],"contexts":[],"lifecycle":"active","narrative":{"causes":[],"contentForm":"definition-only","matchMethod":"same-ontology-node","name":"hyperprolinemia type 1","paragraphs":["Hyperprolinaemia type I is an inborn error of proline metabolism characterized by elevated levels of proline in the plasma and urine. The prevalence is unknown. The disorder is generally considered to be benign but associations with renal abnormalities, epileptic seizures, and other neurological manifestations, as well as certain forms of schizophrenia have been reported. It is transmitted as an autosomal recessive trait and is caused by mutations in the proline dehydrogenase or proline oxidase gene (PRODH or POX, 22q11.2)."],"scope":"exact","source":"MONDO","upstream":"Orphanet:419","url":"https://monarchinitiative.org/MONDO:0009400"},"ownColumnKeys":["population-e82009dfd802bfc801d4","population-83f5feb320768048a66a"],"publication":"published","relationships":[{"kind":"parent","label":"hyperprolinemia","mondoId":"MONDO:0023419","slug":"hyperprolinemia"}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[{"reason":"Public source record is not available in the frozen inputs","source":"GARD","url":"https://rarediseases.info.nih.gov/diseases/24670"}],"translation":"published"},"records":[{"frequencyKind":"range","key":"0ce954ae410912b0d008ede4f1550503ed0e267e50deac541bb74a2df6e4ef09","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:419","disease_name":"Hyperprolinemia type 1","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0100753","is_excluded":false,"label":"Schizophrenia","onset_id":null,"reference":"ORPHA:419","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"13f6599e6bf10c402b470ef616e93f065838cea0a870fdd18cc5f81e8f17e8ad","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:239500","disease_name":"Hyperprolinemia, type I","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0001252","is_excluded":false,"label":"Hypotonia","onset_id":null,"reference":"OMIM:239500","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"1cbb9bf40de31b0ab0805af27cf5917fec22163d22a22c2e3d22700ef6f880f0","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:239500","disease_name":"Hyperprolinemia, type I","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0000733","is_excluded":false,"label":"Motor stereotypy","onset_id":null,"reference":"OMIM:239500","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"1fd75d7cd3c6bcd740eae467c0e70289f4cfc73b40174963cbce0e5def5de9c3","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:419","disease_name":"Hyperprolinemia type 1","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0000093","is_excluded":false,"label":"Proteinuria","onset_id":null,"reference":"ORPHA:419","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"3172f9ab80ecd4440659a4aecf00d614bfcfb32b6d0dc50cf836ff3f3bc2d42c","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:239500","disease_name":"Hyperprolinemia, type I","evidence":"PCS","frequency_raw":null,"hpo_id":"HP:0003137","is_excluded":false,"label":"Prolinuria","onset_id":null,"reference":"PMID:11510941","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"33fb939f796da244c6099da224d47b2a4dd8318f7888f86dd1047cb0bc8efe0f","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:419","disease_name":"Hyperprolinemia type 1","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0001250","is_excluded":false,"label":"Seizure","onset_id":null,"reference":"ORPHA:419","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"346bf343cdc9a00c0800b36c2b3326321de2d47686d8b0eef4f69fc89969cf2d","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:239500","disease_name":"Hyperprolinemia, type I","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0002353","is_excluded":false,"label":"EEG abnormality","onset_id":null,"reference":"OMIM:239500","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"count","key":"38f5f3c7cc2332adb487043904c80a40efd7c86643ed2983710e2a2dc99581a3","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:239500","disease_name":"Hyperprolinemia, type I","evidence":"PCS","frequency_raw":"13/19","hpo_id":"HP:0001250","is_excluded":false,"label":"Seizure","onset_id":null,"reference":"PMID:20524212","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"440f3e323bff118d3e26cdae823667be6b1cc563b9b6496e6b89ebcb3f92e5d5","raw":{"aspect":"P","body_system":"genitourinary","disease_id":"ORPHA:419","disease_name":"Hyperprolinemia type 1","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0000112","is_excluded":false,"label":"Nephropathy","onset_id":null,"reference":"ORPHA:419","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"4bae7a9cc2d5b500b602965cd27b0c8c59a4c81fedbfacea707e01e4fdb49e3b","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:419","disease_name":"Hyperprolinemia type 1","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0003137","is_excluded":false,"label":"Prolinuria","onset_id":null,"reference":"ORPHA:419","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"4ebccbbad7048098d1810fccc3dc7dda92fd971818f9993649bc5fa45aa21af6","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:239500","disease_name":"Hyperprolinemia, type I","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0003080","is_excluded":false,"label":"Hydroxyprolinuria","onset_id":null,"reference":"OMIM:239500","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"count","key":"5647f554fd1f9ab5bd410234dafe5a4f15aff16b5750f316eb85391be2219055","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:239500","disease_name":"Hyperprolinemia, type I","evidence":"PCS","frequency_raw":"2/3","hpo_id":"HP:0003108","is_excluded":false,"label":"Hyperglycinuria","onset_id":null,"reference":"PMID:23462603","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"650b36fb138a6338b42644d9fda33283093ad9d12cac3bf94a452ef9cef98482","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:239500","disease_name":"Hyperprolinemia, type I","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0001290","is_excluded":false,"label":"Generalized hypotonia","onset_id":null,"reference":"OMIM:239500","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"count","key":"84d03eed7b7987d4a7cf4d852e59d7a84cfe48e48bf403cbf24b3a2171e79adc","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:239500","disease_name":"Hyperprolinemia, type I","evidence":"PCS","frequency_raw":"4/4","hpo_id":"HP:0000750","is_excluded":false,"label":"Delayed speech and language development","onset_id":null,"reference":"PMID:17412540","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"8b73a61b4ec70b9c923900ca5c03635ec5fb9bc2bc8a50296d80b3eaefd9d58c","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:239500","disease_name":"Hyperprolinemia, type I","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0100753","is_excluded":false,"label":"Schizophrenia","onset_id":null,"reference":"OMIM:239500","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"count","key":"ad113bfd349c92835fedd595ba3a540543574e8e6fbede90d27c7b9e1ba7ab97","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:239500","disease_name":"Hyperprolinemia, type I","evidence":"PCS","frequency_raw":"7/23","hpo_id":"HP:0001251","is_excluded":false,"label":"Ataxia","onset_id":null,"reference":"PMID:17412540;PMID:20524212","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"ae56960bd0d7e9f9aa0dc546a33debe5ad252ddb02dc2364c0c5964d65d7223a","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:239500","disease_name":"Hyperprolinemia, type I","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0000718","is_excluded":false,"label":"Aggressive behavior","onset_id":null,"reference":"OMIM:239500","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"count","key":"aedb75782fcb68c3c361371e8ada2a760c03d8cddd3475d64ab87c86076e8c3d","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:239500","disease_name":"Hyperprolinemia, type I","evidence":"PCS","frequency_raw":"14/23","hpo_id":"HP:0001263","is_excluded":false,"label":"Global developmental delay","onset_id":null,"reference":"PMID:17412540;PMID:20524212","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"ba6549bf27fd8795134b5ed0f1535c179adb973d23e2b3fecdcde6efc13c8699","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:239500","disease_name":"Hyperprolinemia, type I","evidence":"PCS","frequency_raw":"14/14","hpo_id":"HP:0008358","is_excluded":false,"label":"Hyperprolinemia","onset_id":null,"reference":"PMID:17412540;PMID:20524212","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"c33ebd59e91d60790a1dfeef1d0431d76a22c409b3e69d6d8b2afc8b4d0607eb","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:239500","disease_name":"Hyperprolinemia, type I","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0002133","is_excluded":false,"label":"Status epilepticus","onset_id":null,"reference":"OMIM:239500","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"c645b3c917a49e480b9d7b52ac3e8a9b9b711e486afd92df31e55043c8d6b21f","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:239500","disease_name":"Hyperprolinemia, type I","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0000752","is_excluded":false,"label":"Hyperactivity","onset_id":null,"reference":"OMIM:239500","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"count","key":"e0086ecc17497a1d39d3bb438ef0d6fb2bea20e96463ecc91cb995873c3dac9c","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:239500","disease_name":"Hyperprolinemia, type I","evidence":"PCS","frequency_raw":"3/19","hpo_id":"HP:0000729","is_excluded":false,"label":"Autistic behavior","onset_id":null,"reference":"PMID:20524212","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"e93d951b3e5e9f3b652196df1e998e57c1a5213ffc1e306b89acc1f1702edb03","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:419","disease_name":"Hyperprolinemia type 1","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0008358","is_excluded":false,"label":"Hyperprolinemia","onset_id":null,"reference":"ORPHA:419","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"count","key":"f58b526160feee7de6348b47adbb0cfd6bd89e7ecc722bcd225a08ae4e1409b5","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:239500","disease_name":"Hyperprolinemia, type I","evidence":"TAS","frequency_raw":"20/20","hpo_id":"HP:0001249","is_excluded":false,"label":"Intellectual disability","onset_id":null,"reference":"OMIM:239500","source_release":"2026-06-23"},"sourceGroups":["omim"]}],"referenceLabels":{},"references":{"causeHtml":"<p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0009400\" rel=\"noreferrer\">MONDO</a></p><details class=\"deep-dive\"><summary>Narrative source and scope</summary><dl><dt>Content</dt><dd>definition-only</dd><dt>Scope</dt><dd>exact</dd><dt>Match method</dt><dd>same-ontology-node</dd><dt>Upstream attribution</dt><dd>Orphanet:419</dd></dl></details>","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>Hyperprolinaemia type I is an inborn error of proline metabolism characterized by elevated levels of proline in the plasma and urine. The prevalence is unknown. The disorder is generally considered to be benign but associations with renal abnormalities, epileptic seizures, and other neurological manifestations, as well as certain forms of schizophrenia have been reported. It is transmitted as an autosomal recessive trait and is caused by mutations in the proline dehydrogenase or proline oxidase gene (PRODH or POX, 22q11.2).</p><p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0009400\" rel=\"noreferrer\">MONDO</a></p>","key":"overview","title":"Brief description"}],"sharedSources":[],"slug":"hyperprolinemia-type-1","sourceDocuments":[{"name":"MONDO: hyperprolinemia type 1","reviewed":null,"source_release":"releases/2026-10-06","url":"https://monarchinitiative.org/MONDO:0009400"}],"sourceNote":"","synonyms":["HPI","hyperprolinemia caused by mutation in PRODH","hyperprolinemia type 1","hyperprolinemia, type I","HYRPRO1","PRODH hyperprolinemia","proline oxidase deficiency"],"takeawayHtml":"","title":"hyperprolinemia type 1"},"schemaVersion":1}
